Alcon (NYSE:ALC) announced today that it completed its $475 million acquisition of glaucoma surgery device maker Ivantis. Geneva, Switzerland-based Alcon initially announced the acquisition of Ivantis, which develops the Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device, in November 2021. According to a news release, the … [Read more...] about Alcon closes Ivantis acquisition
Research & Development
CardioMech reports first in-person procedure with its transcatheter mitral valve repair tech
CardioMech confirmed the completion of the first procedure with its transcatheter mitral valve repair (TMVR) technology. At the Sanger Heart & Vascular Institute in North Carolina, a multidisciplinary heart team evaluated a patient diagnosed with severe symptomatic degenerative mitral regurgitation (DMR). They offered the patient a choice: … [Read more...] about CardioMech reports first in-person procedure with its transcatheter mitral valve repair tech
What is renal denervation? Medtronic Coronary and RDN President Jason Weidman explains
Medtronic (NYSE:MDT) continues clinical trials of its Symplicity Spyral renal denervation (RDN) system for treating hypertension. The hope now is to win FDA approval in 2023. To better understand the technology behind what Medtronic leaders expect to become a multibillion-dollar business, Medical Design & Outsourcing spoke with Jason … [Read more...] about What is renal denervation? Medtronic Coronary and RDN President Jason Weidman explains
Edwards touts trial results for Evoque transcatheter tricuspid valve replacement system
Edwards Lifesciences (NYSE:EW) shared data from a clinical trial showing that its Evoque transcatheter tricuspid valve replacement offers favorable patient outcomes. Irvine, California–based Edwards presented the data during the late-breaking clinical science session at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), according to a … [Read more...] about Edwards touts trial results for Evoque transcatheter tricuspid valve replacement system
Sapien 3 TAVR offers improved outcomes, reduced cost, Edwards Lifesciences says
Edwards Lifesciences (NYSE:EW) today touted a cost-effectiveness analysis that supports transcatheter aortic valve replacement (TAVR) with the Sapien 3. Irvine, California-based Edwards presented data from the Partner 3 trial during the late-breaking clinical trials at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), the annual … [Read more...] about Sapien 3 TAVR offers improved outcomes, reduced cost, Edwards Lifesciences says
Medtronic touts 5-year study of self-expanding TAVR platform
Medtronic (NYSE:MDT) today presented five-year clinical data for its CoreValve and Evolut transcatheter aortic valve implantation (TAVI) platforms. Fridley, Minnesota-based Medtronic presented results from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial at the 33rd Transcatheter Cardiovascular Therapeutics … [Read more...] about Medtronic touts 5-year study of self-expanding TAVR platform
Medtronic faces longer road to renal denervation
Medtronic (NYSE:MDT) will continue the clinical study of its Symplicity Spyral renal denervation (RDN) system for hypertension into next year after lacking the positive results needed to end enrollment early. Fridley, Minnesota-based Medtronic said last month that it hoped to present results of the Spyral HTN-ON MED trial at the Cardiovascular … [Read more...] about Medtronic faces longer road to renal denervation
How a future-minded medtech engineer finds inspiration, innovation and creativity
The future of medtech is the focus of TE Connectivity’s Advanced Technology Group, a team of experienced engineers tasked with identifying trends and developing new technology for devices and challenges that might not yet even exist. Marie Ottum, principal R&D engineer in TE Connectivity’s Advanced Technology Group and global leader of the … [Read more...] about How a future-minded medtech engineer finds inspiration, innovation and creativity
FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings. Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory … [Read more...] about FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
This device stops aorta blood flow to save lives
Stopping internal bleeding from torso trauma has its technological challenges. Asha Parekh, co-founder and CEO of Front Line Medical Technologies, has developed a small, quick and easy device that could solve the problem. Front Line Medical Technologies (London, Ontario) is an early-stage medical device company that is developing a way to stop … [Read more...] about This device stops aorta blood flow to save lives